Find Diammonium Citrate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 3012-65-5, Microstop, Diammonium hydrogen citrate, Dibasic ammonium citrate, Ammonium monohydrogen citrate, Ammonium citrate, dibasic
Molecular Formula
C6H14N2O7
Molecular Weight
226.18  g/mol
InChI Key
YXVFQADLFFNVDS-UHFFFAOYSA-N

Diammonium Citrate
1 2D Structure

Diammonium Citrate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
diazanium;3-carboxy-3-hydroxypentanedioate
2.1.2 InChI
InChI=1S/C6H8O7.2H3N/c7-3(8)1-6(13,5(11)12)2-4(9)10;;/h13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);2*1H3
2.1.3 InChI Key
YXVFQADLFFNVDS-UHFFFAOYSA-N
2.1.4 Canonical SMILES
C(C(=O)[O-])C(CC(=O)[O-])(C(=O)O)O.[NH4+].[NH4+]
2.2 Synonyms
2.2.1 MeSH Synonyms

1. Da-h-c Cpd

2. Diammonium Hydrogen Citrate

2.2.2 Depositor-Supplied Synonyms

1. 3012-65-5

2. Microstop

3. Diammonium Hydrogen Citrate

4. Dibasic Ammonium Citrate

5. Ammonium Monohydrogen Citrate

6. Ammonium Citrate, Dibasic

7. Citric Acid Diammonium Salt

8. Ammonium Citrate Dibasic

9. Ammonium Hydrogen Citrate

10. Ammonium Monohydrogencitrate

11. Citrate (diammonium)

12. 2-hydroxy-1,2,3-propanetricarboxylic Acid, Diammonium Salt

13. Mfcd00013068

14. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Diammonium Salt

15. Ammcitrate

16. Diammonium 3-carboxy-3-hydroxypentanedioate

17. Diammonium Hydrogen 2-hydroxypropane-1,2,3-tricarboxylate

18. Citric Acid Ammonium Salt

19. Ammonium Monohydrogen Citrate; Citrate Diammonium Hydrogen

20. Ammonium Monohydrogencitrat

21. N9bug430k8

22. Chebi:63076

23. Citric Acid, Diammonium Salt

24. Diammonium Citrate (secondary)

25. Hsdb 300

26. Einecs 221-146-3

27. Unii-n9bug430k8

28. Ai3-26173

29. Diammonium 2-hydroxy-1,2,3-propanetricarboxylate

30. Ammonium Citrate Dibasic Acs Granular

31. Diazanium;3-carboxy-3-hydroxypentanedioate

32. Db-047712

33. 1,2,3-propanetricarboxylic Acid, 2-hydroxy-, Ammonium Salt (1:2)

2.3 Create Date
2005-07-19
3 Chemical and Physical Properties
Molecular Weight 226.18 g/mol
Molecular Formula C6H14N2O7
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count7
Rotatable Bond Count3
Exact Mass226.08010079 g/mol
Monoisotopic Mass226.08010079 g/mol
Topological Polar Surface Area140 Ų
Heavy Atom Count15
Formal Charge0
Complexity216
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count3
4 Pharmacology and Biochemistry
4.1 Absorption, Distribution and Excretion

...The distribution of (15)N from ammonium citrate, administered by different routes, into the proteins of various tissues of hypophysectomized rats /was examined/. The liver, kidney, and spleen contained greater concentrations of (15)N incorporated into proteins than heart or muscle fractions during 72 hr following intragastric, intraperitoneal, and subcutaneous administration of 15N-ammonium citrate. After the first 6 hr, during which the intragastric route gave higher values, the quantity of (15)N incorporated into liver-protein was not substantially affected by the route of administration. In most of the other tissues studied, however, (15)N incorporation tended to be least by the intragastric route, followed, in increasing order, by the intraperitoneal and subcutaneous routes. By the last route, more labelled ammonia was apparently made available to the widely distributed glutamine-synthetase (EC 6.3.1.2) system. /Ammonium citrate/

WHO; Environ Health Criteria 54: Ammonia p.105 (1986)


4.2 Metabolism/Metabolites

Results of studies on the metabolic fate of dietary ammonium citrate and intravenously-administered ammonium lactate in rats showed that urea synthesis represented a nearly constant fraction of the administered ammonia over a large concentration range. Besides glutamine and urea, labelled nitrogen also appeared in creatine, glycine, alanine, proline, histidine, arginine, glutamic acid, and aspartic acid. ...The incorporation of (15)N from ammonium citrate into proteins of liver, heart, kidney, spleen, and muscle fractions of untreated and growth hormone-treated, hypophysectomized rats /was examined/, and found differences in the metabolic fate, depending on the route of administration. Subcutaneous injection facilitated the labelling of amide nitrogen, indicating extensive disposition via glutamine synthesis. In contrast, intragastric or intraperitoneal administration resulted in the labelling of arginine, glutamic acid, and other alpha-amino acids of the liver. Amide-nitrogen was labelled to a much lesser extent than by the subcutaneous route. The tissue distribution of the label also differed according to the route of entry. /Ammonium citrate/

WHO; Environ Health Criteria 54: Ammonia p.106 (1986)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty